Semaglutide: difference between revisions
Diff·revision 12 → 13·10:04, 30 Oct 2024
Difference between revision 12 and revision 13 of Semaglutide. 1 line changed; the page grew by 30 bytes.
| Revision 12 — 23:17, 8 Oct 2024 SecretagogueSol (talk) state plainly that the research-use-only form is not approved for human use 5,578 bytes +567 | Revision 13 — 10:04, 30 Oct 2024 OrforglipronOona (talk) convert the substitution list to a table so the analogues line up 5,608 bytes +30 | ||
|---|---|---|---|
| 1 | {{Infobox compound | 1 | {{Infobox compound |
| 2 | | name = Semaglutide | 2 | | name = Semaglutide |
| + | 3 | | subtitle = Clinical data | |
| 3 | | image = peptide-chain.svg | 4 | | image = peptide-chain.svg |
| 4 | | caption = A 31-residue backbone with Aib at position 8 and a C-18 diacid on Lys26 through a γ-Glu-2×OEG spacer. | 5 | | caption = A 31-residue backbone with Aib at position 8 and a C-18 diacid on Lys26 through a γ-Glu-2×OEG spacer. |